Lauranne Scheldeman

Nov 20, 2024 | medrxiv.org | Felix L. Naegele |Anke Wouters |Marlene Heinze |Lauranne Scheldeman

F.L.N., L.S., A.W., M.H., M.P., E.S., M.S., M. Ebinger, R.L., N.N., S.P., J.P., V.T., and B.C. declare no conflicts of interest in relation to this study. L.S. reports fees for congress participation from Angelini Pharma outside the submitted work. M. Endres reports grants from Bayer and fees paid to the Charite from Amgen, Astra-Zeneca, Bayer Healthcare, Boehringer Ingelheim, BMS, Daiichi Sankyo, Sanofi, Pfizer, all outside the submitted work.